AETHLON MEDICAL INC — financial figures as filed

CIK 882291 · 16 fiscal years on record

Every figure below is taken from a filed report through an explicit tag map and carries the tag and accession number it came from. A metric the company did not disclose is shown as , never as zero.

Aggregates

computed from the figures below
Metrics filled
11 / 12
canonical metrics mapped from the filings
Mapping completeness
91.7%
1 not disclosed
Fiscal years on record
16
Quarters on record
33
Revenue change, latest year
100.0%
against the preceding fiscal year
Revenue growth run
0 yr
consecutive years higher than the previous
Years with income above zero
0
16 years below zero on record
Revenue rank in peer group
615 / 629
by latest annual revenue
Disclosure lag
88 d
period end to filing date
Latest period end
2024-03-31
filed 2024-06-27
Periods that do not reconcile
0
four quarters against the reported year

Explainable annual analytics

latest annual period where both published inputs exist
Ratios are arithmetic over reported SEC facts, not ratings, forecasts or investment advice.
MetricValueFiscal yearInputsSource tags
Return on assets-112.9%FY2026Net income: -$7.2MTotal assets: $6.3MNetIncomeLoss / Assets
Return on equity-146.4%FY2026Net income: -$7.2MShareholders equity: $4.9MNetIncomeLoss / StockholdersEquity
Liabilities / assets22.8%FY2026Total liabilities: $1.4MTotal assets: $6.3MLiabilities / Assets
Cash / assets79.4%FY2026Cash and equivalents: $5MTotal assets: $6.3MCashAndCashEquivalentsAtCarryingValue / Assets

Not computed: Gross margin — both metrics are not available for a common annual period; Operating margin — the published denominator is zero; Net margin — the published denominator is zero; Operating cash-flow margin — the published denominator is zero.

Mapping completeness

11 of 12

11 of 12 canonical metrics were filled from this company's filings through the explicit tag map. Tags outside that map are recorded and counted, and are never used as a value.

Not on record for this company: Gross profit. This means the figure was not disclosed in a form we accept, not that it is zero.

Revenue by fiscal year

annual, as filed
  • 2015$762.4K
  • 2016$886.6K
  • 2017$392.1K
  • 2018$149.6K
  • 2019$229.6K
  • 2020$650.2K
  • 2021$659.1K
  • 2022$294.2K
  • 2023$574.2K
  • 2024$0

Net income by fiscal year

annual, as filed
  • 2017-$7.3M
  • 2018-$5.7M
  • 2019-$6.2M
  • 2020-$6.4M
  • 2021-$7.9M
  • 2022-$10.4M
  • 2023-$12M
  • 2024-$12.2M
  • 2025-$13.4M
  • 2026-$7.2M

Revenue by fiscal quarter

quarterly, as filed

Annual figures

12 fiscal years shown
Metric202620252024202320222021202020192018201720162015
Revenue$0$574.2K$294.2K$659.1K$650.2K$229.6K$149.6K$392.1K$886.6K$762.4K
Operating income-$7.3M-$9.3M-$12.6M-$11.9M-$10.4M-$7.9M-$5.9M-$6M-$4.8M-$6.1M-$4.4M-$4M
Net income-$7.2M-$13.4M-$12.2M-$12M-$10.4M-$7.9M-$6.4M-$6.2M-$5.7M-$7.3M-$4.9M-$6.8M
Operating cash flow-$7M-$7.6M-$10.1M-$10.5M-$9.8M-$6.8M-$5.2M-$4.3M-$3.9M-$3.5M-$4.3M-$5M
Total assets$6.3M$7.4M$8.2M$17.5M$19.4M$10.7M$10.4M$4.1M$7.4M$1.7M$2.6M$1.4M
Total liabilities$1.4M$2.2M$2.5M$2.4M$2.4M$1.4M$1.1M$1.8M$1.3M$1.1M$1.1M$729.2K
Shareholders equity$4.9M$5.1M$5.8M$15.1M$17.1M$9.4M$9.4M$2.4M$6.1M$676.4K$1.6M$615.5K
Cash and equivalents$5M$5.5M$5.4M$14.5M$17.1M$9.9M$9.6M
Shares outstanding1,570,4492,010,7392,629,72522,992,46615,419,16312,150,5979,367,1711,266,97917,739,5118,797,0867,622,3936,657,046
EPS, basic-$10.61-$8.58-$4.86-$0.59-$0.71-$0.65-$1.87-$5.13-$0.10-$0.94-$0.66-$1.22
EPS, diluted-$10.61-$8.58-$4.86-$0.59-$0.71-$0.65-$1.87-$5.13-$0.10-$0.94-$0.66-$1.22

Quarterly figures

12 fiscal quarters shown
Metric2026 Q32026 Q22026 Q12025 Q32025 Q22025 Q12024 Q32024 Q22024 Q12023 Q32023 Q22023 Q1
Revenue$0$0$0
Operating income-$2.1M-$1.5M-$1.8M-$1.8M-$2.9M-$2.6M-$3.6M-$3.2M-$3.4M-$2.8M-$3.7M-$2.9M
Net income-$2M-$1.5M-$1.8M-$1.8M-$2.8M-$2.6M-$3.5M-$3M-$3.3M-$2.8M-$3.8M-$2.9M
Operating cash flow-$1.7M-$1.7M-$2.5M-$2.7M
Total assets$8.1M$7.3M$5.3M$6.5M$8.8M$11.4M$10.4M$12.8M$15.8M$20.7M$23M$17.1M
Total liabilities$1.3M$1.6M$1.9M$2.2M$2.8M$2.7M$2.8M$2.5M$2.7M$3.4M$3.2M$2.2M
Shareholders equity$6.7M$5.7M$3.4M$4.3M$6M$8.7M$7.6M$10.3M$13.1M$17.3M$19.9M$14.9M
Cash and equivalents$7M$5.9M$3.8M$4.8M$6.9M$9.1M$8M$10.2M$12.9M$17.5M$19.6M$14.9M
Shares outstanding973,213761,3182,598,71113,986,66913,961,99813,937,3272,596,5382,492,90824,835,32122,969,34922,946,23215,993,723
EPS, basic-$2.45-$3.74-$0.85-$0.13-$0.20-$0.34-$1.37-$1.22-$1.35-$0.12-$1.84-$0.19
EPS, diluted-$2.45-$3.74-$0.85-$0.13-$0.20-$0.34-$1.37-$1.22-$1.35-$0.12-$1.84-$0.19

Latest figure against the peer median

all 722 companies with figures on record
An industry classification is not on record for this company, so the comparison group is every company whose figures we hold, across all sectors. The median is stated with the group it was computed over; it is a fact about that group and nothing more.
MetricLatest annual figurePeer medianDifferenceCompanies in groupSource tag
Revenue · FY2024$0$422.2M 100.0%629Revenues
Operating income · FY2026-$7.3M-$3.8M 92.2%591OperatingIncomeLoss
Net income · FY2026-$7.2M$2.4M 392.3%716NetIncomeLoss
Operating cash flow · FY2026-$7M$20.1M 134.8%715NetCashProvidedByUsedInOperatingActivities
Total assets · FY2026$6.3M$1.1B 99.4%720Assets
Total liabilities · FY2026$1.4M$458.2M 99.7%664Liabilities
Shareholders equity · FY2026$4.9M$301M 98.4%716StockholdersEquity
Cash and equivalents · FY2026$5M$82.6M 93.9%688CashAndCashEquivalentsAtCarryingValue
Shares outstanding · FY20261,570,44949,628,137 96.8%606CommonStockSharesOutstanding
EPS, basic · FY2026-$10.61$0.05 21,320.0%678EarningsPerShareBasic
EPS, diluted · FY2026-$10.61$0.03 42,540.0%678EarningsPerShareDiluted

Where the numbers come from

every figure traces to a filing
MetricFiscal periodPeriod endFiledFormAccessionXBRL tag
RevenueFY20242024-03-312024-06-2710-K0001683168-24-004530Revenues
Operating incomeFY20262026-03-312026-06-1010-K0001683168-26-004710OperatingIncomeLoss
Net incomeFY20262026-03-312026-06-1010-K0001683168-26-004710NetIncomeLoss
Operating cash flowFY20262026-03-312026-06-1010-K0001683168-26-004710NetCashProvidedByUsedInOperatingActivities
Total assetsFY20262026-03-312026-06-1010-K0001683168-26-004710Assets
Total liabilitiesFY20262026-03-312026-06-1010-K0001683168-26-004710Liabilities
Shareholders equityFY20262026-03-312026-06-1010-K0001683168-26-004710StockholdersEquity
Cash and equivalentsFY20262026-03-312026-06-1010-K0001683168-26-004710CashAndCashEquivalentsAtCarryingValue
Shares outstandingFY20262026-03-312026-06-1010-K0001683168-26-004710CommonStockSharesOutstanding
EPS, basicFY20262026-03-312026-06-1010-K0001683168-26-004710EarningsPerShareBasic
EPS, dilutedFY20262026-03-312026-06-1010-K0001683168-26-004710EarningsPerShareDiluted

Source: U.S. Securities and Exchange Commission, EDGAR company facts · as of 2024-06-27

AETHLON MEDICAL INC financial figures — 16 fiscal years on record — Tapewire